Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Shares Outstanding (2016 - 2025)

Veracyte (VCYT) has disclosed Shares Outstanding for 14 consecutive years, with $79.4 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 2.04% to $79.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $79.4 million through Dec 2025, up 2.04% year-over-year, with the annual reading at $79.4 million for FY2025, 2.04% up from the prior year.
  • Shares Outstanding hit $79.4 million in Q4 2025 for Veracyte, roughly flat from $79.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $79.4 million in Q4 2025 to a low of $67.2 million in Q1 2021.
  • Historically, Shares Outstanding has averaged $73.9 million across 5 years, with a median of $72.8 million in 2023.
  • Biggest five-year swings in Shares Outstanding: skyrocketed 34.47% in 2021 and later increased 1.0% in 2022.
  • Year by year, Shares Outstanding stood at $71.1 million in 2021, then grew by 1.18% to $72.0 million in 2022, then grew by 1.81% to $73.3 million in 2023, then grew by 6.15% to $77.8 million in 2024, then rose by 2.04% to $79.4 million in 2025.
  • Business Quant data shows Shares Outstanding for VCYT at $79.4 million in Q4 2025, $79.0 million in Q3 2025, and $78.6 million in Q2 2025.